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A reverse transcriptase (RT)-polymerase chain reaction (PCR)-oligoprobe (OP), or RT-PCR-OP, method
was developed for the detection of the Norwalk virus, which causes acute, epidemic gastroenteritis, in stool
specimens. The Norwalk virus genome regions encoding the following two proteins were amplified by RT-PCR:
the RNA polymerase (260-bp product) and a putative immunogenic protein (224-bp product). The resulting
DNA fragments (amplicons) were hybridized to a digoxigenin-labeled internal OP specific to each amplicon.
The detection limit of Norwalk virus, as determined by the endpoint of RT-PCR amplification for serially
diluted, positive stool specimens, was similar to the actual virion titer as estimated by electron microscopy and
at least 100-fold greater than the titer determined by radioimmunoassay (RIA). The RT-PCR-OP assay was
specific for Norwalk virus and negative for other enteric viruses, including human and animal caliciviruses,
hepatitis E virus, Snow Mountain agent, astroviruses, 16 human enteroviruses, and 5 human rotaviruses.
Components of fecal specimens that interfere with RT-PCR were removed successfully by Sephadex G-200 gel
chromatography. Of 20 stool specimens from human volunteers that were positive for Norwalk virus by RIA,
a specific RT-PCR-OP result was obtained in 95% (19 of 20) of the samples by using the immunogenic protein
primers and 75% (15 of 20) by using the polymerase primers. Twenty-six stool specimens from asymptomatic
children and adults were negative by the Norwalk virus RT-PCR-OP. RT-PCR-OP detected Norwalk virus in
the 4 of 21 coded fecal specimens that were also positive by enzyme immunoassay. Two samples that were
positive by RIA or enzyme immunoassay were negative by RT-PCR, perhaps because viral RNA was not
present or RT-PCR inhibitors were not adequately removed.
Norwalk virus is a major cause of gastroenteritis in older
children and adults (1, 14) and is associated with epidemic
disease in families, schools, other institutional settings, and
communitywide outbreaks caused by contaminated water
and food (2, 15). It is the prototype member of a poorly
defined group of small, round gastrointestinal viruses that
cause epidemic diarrhea (7, 9, 14). Approximately 42% of
outbreaks of acute nonbacterial gastroenteritis investigated
by the Centers for Disease Control during 1976 to 1981 were
caused by Norwalk virus and Norwalk virus-like viruses
(15). The major clinical features of Norwalk gastroenteritis
are nausea, vomiting, diarrhea, abdominal cramps, and
headache lasting between 12 and 60 h (14, 15). Antibodies to
Norwalk virus have been detected in the populations of
many industrialized and developing countries, indicating a
worldwide distribution (1). Previous studies on Norwalk
virus proteins and more recent studies on the cloning and
partial sequencing of its nucleic acid have established that
Norwalk virus is most likely a calicivirus (10, 13, 17).
The diagnosis of Norwalk virus gastroenteritis is currently
based on clinical observations combined with the detection
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of viral antigens or patient seroconversion. Identification of
Norwalk virus by direct electron microscopy is often not
possible because its surface morphology is not sufficiently
distinctive and the virus is shed in feces in relatively low
numbers (10W to 106/g of feces) (14). Immune electron micros-
copy (IEM) can be used to observe viral particles that have
been specifically aggregated with postinfection serum, but
this method is tedious and insensitive. Currently, radioimmu-
noassay (RIA) and enzyme immunoassay (EIA) are the
methods of choice for identification of Norwalk virus infec-
tions because they are more efficient than and are at least as
sensitive as IEM in detecting viral antigens or antibodies (11).
However, these diagnostic tests currently have limited appli-
cation in clinical laboratories because reagent quality and
Norwalk virus-specific antigens and antibodies are not widely
available and because both acute- and convalescent-phase
sera are required to diagnose suspected cases serologically. A
specific and generally accessible diagnostic test for Norwalk
virus, one that does not cross-react with other small, round
gastrointestinal viruses or other enteric viruses, is needed.
The cloning of a large portion of the Norwalk virus
genome and the availability of nucleotide sequence data for
genomic regions encoding the RNA polymerase (Pol) (13)
and an immunogenic protein (IP) (17) have made possible the
detection of Norwalk virus RNA by cDNA probe hybridiza-
tion (17). Furthermore, it should now be possible to develop
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highly sensitive methods to detect Norwalk virus in clinical
specimens by reverse transcriptase (RT)-polymerase chain
reaction (PCR).
Detection of enteric viruses in fecal specimens by RT-PCR
has been described recently for a number of viruses includ-
ing group A rotaviruses (8, 23), group B rotaviruses (6),
enteroviruses (21), and hepatitis A virus (12, 20). In most of
these studies, viral RNA was isolated by conventional
phenol-chloroform extraction and ethanol precipitation, and
in some studies (6, 23), the viral RNA was further processed
for removal of RT-PCR inhibitors by adsorption to and
elution from CF-11 cellulose. These sample preparation
methods are cumbersome and time-consuming and are not
readily applicable in clinical laboratories. Likewise, the
removal of RT-PCR inhibitors by antigen-capture PCR (12)
is not feasible at present, because the required monoclonal
or monospecific antibodies for Norwalk virus are not yet
available. It is clear that a rapid and simple method for fecal
specimen preparation is needed for routine detection of
Norwalk virus by RT-PCR. In this report, we describe an
efficient and widely applicable technique that can be used to
detect Norwalk virus in fecal specimens. Our approach
consisted of partial purification of virus from fecal material
by spin-column chromatography (3); this was followed by
RT-PCR amplification and confirmation of RT-PCR product
specificity by use of a nonradioactive oligoprobe (OP).
MATERIALS AND METHODS
Viruses and stool specimens. Norwalk virus was obtained
as stool samples from human volunteers experimentally
infected with the 8FIIa Norwalk inoculum (a gift of G. W.
Gary, Centers for Disease Control, Atlanta, Ga.). Additional
stool specimens containing the Norwalk virus-like or calici-
virus-like viruses designated Hawaii agent, Parramatta
agent, Taunton agent, Snow Mountain agent, UK4, 20862,
1120, R, J, and S were obtained from our collections (J.E.H.,
N.R.B., and M.D.S.). Hepatitis E virus in acute-phase stool
specimens from an experimentally infected cynomolgus
monkey was obtained from J. Ticehurst (Walter Reed Army
Institute for Research, Washington, D.C.). Coxsackievirus
type Al was obtained as homogenized mouse tissue from the
American Type Culture Collection (Rockville, Md.). The
following cell culture-propagated viruses were obtained from
the indicated sources: feline caliciviruses 2280 and LLK, F.
Schaffer (Naval Biomedical Research Laboratory, Oakland,
Calif.); human rotavirus strain Wa and isolate 62 (type 1),
isolate 126 (type 2), strain P (type 3), and isolate 204 (type 4),
R. L. Ward (The Christ Hospital Institute of Medical Re-
search, Cincinnati, Ohio); human astrovirus types 1, 2, and
4, J. E. Herrmann; and hepatitis A virus (strain HM175),
polioviruses 1 and 3, coxsackieviruses types A5, A9, A12,
A17, B3, and B4, and echoviruses 1, 2, 4, 5, 7, and 12, the
collection of M. D. Sobsey.
Sample processing for PCR. Ten or 20% stool suspensions
in phosphate-buffered saline were clarified by centrifugation
(1,000 x g) for 5 min and were filter sterilized through
0.45-,um-pore-size membrane filters (Low Protein Binding
Sterile Acrodisc; Gelman Sciences, Ann Arbor, Mich.) that
had been pretreated with 0.1% Tween 80 and washed with
sterile distilled water. The Norwalk virus-positive stool
suspensions used for the initial studies were fluorocarbon
(1,1,2-trichloro-1,2,2,-trifluoroethane; Fisher Scientific, Fair
Lawn, N.J.) extracted prior to clarification and filtration.
When a stool sample was available in only a small quantity
(<100 lI), it was clarified by centrifugation at 14,000 x g for
TABLE 1. Norwalk virus primers and oligoprobes








NV-3'IP AGCCTGATAGAGCATTCTTT 45.2 224
NV-Io.IP TGCGTTCACGAGGATGG 62.7
a The Tm of primers was calculated at 50mM salt and solution hybridization
conditions.
b The Td of oligoprobes was calculated at 1,000 mM salt and filter hybrid-
ization conditions (-7.6'C).
c The primers for this region have been published previously (17). The
internal oligomer was selected in this study.
3 to 5 min, and the supernatant was applied directly to the
spin columns. Viruses in the clarified stool sample extracts
were purified by exclusion chromatography by using Seph-
adex G-200 spin columns (bead size, 40 to 120 p,m [diame-
ter]; Pharmacia, Piscataway, N.J.). Spin columns were
prepared as described by Maniatis et al. (16), except that
silane-treated glass wool (Supelco, Bellafonte, Pa.) was used
as the column support. In order to prevent the Sephadex
G-200 gel from crushing under centrifugal force, the columns
were prepared in 3-ml syringes and spun at 400 x g and room
temperature for 4 min. Approximately 75 to 85 ,u of sample
was passed through a 1-ml column (1:12 sample-to-resin
ratio) that had been equilibrated with 0.1 x Taq buffer II
(Perkin Elmer-Cetus, Emeryville, Calif.). Viruses were re-
covered in the excluded volume, which averaged 70 to 80 pl
per column, and 10 pl was used for each RT-PCR. Viruses
grown in cell cultures were diluted 10- to 100-fold in 0.1 x
Taq buffer II (Perkin Elmer-Cetus), and 10 RI containing
approximately 103 to 104 tissue culture infectious units was
used directly for RT-PCR.
Primers and probes. The oligonucleotide primer and probe
sequences used in this study are summarized in Table 1. The
primers NV-5'Pol and NV-3'Pol and the internal oligonucle-
otide probe NV-Io.Pol were selected from published nucle-
otide sequences in the Norwalk virus Pol gene (13). The
primers NV-5'IP and NV-3'IP, from a region encoding an IP,
were those described previously (17), and an internal oligo-
nucleotide, NV-Io.IP, was selected from the known se-
quence data. The Norwalk virus-specific primers and probes
were selected by using computer-aided nucleic acid se-
quence alignments (5) and protein alignments (13, 18) for
caliciviruses and picornaviruses. The internal oligomer
probes NV-Io.Pol and NV-Io.IP were synthesized in the
plus-sense orientation so that they hybridized only with
cDNA or PCR products and not with viral genomic plus-
strand RNA. The DNA oligomers were synthesized as
single-stranded DNA by using an automated synthesizer
(model 392; Applied Biosystems Inc., Foster City, Calif.).
The melting temperatures (Tins) of the primers and the
denaturation temperatures (Tds) of the oligoprobes were
calculated with the aid of the OLIGO program (22).
Reverse transcription and enzymatic amplification (RT-
PCR). The RNA PCR kit from Perkin Elmer-Cetus was used
throughout the study. The manufacturer's instructions were
followed, with the exception that the reaction volume for
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reverse transcription was increased from 20 to 30 pl to
accommodate a 10-,ul virus sample. Random primers were
used during reverse transcription of viral RNA, and primer
pairs for either the Pol gene (NV-Pol) or the IP (NV-IP) were
used for PCR amplification. The reaction mixture was pre-
pared in a single tube and was dispensed into individual
0.6-ml polypropylene reaction tubes for all samples within a
single trial. Each tube was overlaid with 100 lI of mineral oil
(Sigma Chemical Co., St. Louis, Mo.) prior to adding 10 pl
of processed stool sample. Viral RNA was released by
heating the prepared reaction mixtures at 99°C for 5 min in a
thermal cycler (Perkin Elmer-Cetus, Norwalk, Conn.), and
the reaction mixtures were then chilled on ice for 1 min. RT
(2.5 U) and RNase inhibitor (1 U) were subsequently added
beneath the oil as described in the kit. Samples were placed
in the thermal cycler for 10 min at 25°C; this was followed by
a 1-h incubation at 42°C. After cDNA synthesis, sample
tubes were heated to 99°C for 5 min to completely denature
the RT. After brief centrifugation, either NV.Pol or NV.IP
primer pairs and 5 U of Taq polymerase were added to each
tube. Reaction tubes were placed in the thermal cycler when
the block temperature was >85°C. Samples were amplified
in the thermal cycler for 40 cycles by using the cycle
sequence of 95°C for 1.5 min, 50°C (IP region primers) or
55°C (Pol region primers) for 1.5 min, and 72°C for 1.5 min.
After amplification, 10 to 15% of the reaction volumes were
electrophoresed in 2% agarose gels, stained with ethidium
bromide, and visualized by UV light.
OP hybridization. PCR products in agarose gels were
transferred by the method of Southern onto nylon mem-
branes (DuPont, Boston, Mass.). The DNA was bound to
the nylon membranes by cross-linking with shortwave UV
light (Ultraviolet Products Inc., San Gabriel, Calif.) for 3 to
5 min at a distance of 15 cm.
OPs were 3'-end-labeled with digoxigenin-dUTP by using
terminal transferase and were purified by ethanol precipita-
tion, according to the instructions in the Genius nonradio-
active end-labeling kit (Boehringer Mannheim Biochemicals,
Indianapolis, Ind.). The Td of each oligomer was calculated
in 5x SSC (lx SSC is 0.15 M NaCl plus 0.015 M sodium
citrate; 56.7°C for NV-Io.Pol and 56.4°C for NV-Io.IP). OP
hybridization and immunological detection of positive sam-
ples were performed by following the specifications in the kit
(Boehringer Mannhein Biochemicals). Briefly, membranes
were prehybridized for 4 h and were hybridized overnight at
Td - 5°C in the hybridization buffer recommended in the kit
(5x SSC, 0.1% [wt/vol] N-lauroylsarcosine, 0.02% [wt/vol]
sodium dodecyl sulfate, and 1% [wt/vol] proprietary block-
ing reagent of Boehringer Mannheim Biochemicals). The
probe was present at a concentration of 5 to 10 ng per ml of
hybridization solution. The blots were washed five times in
6x SSC-0.05% PPi at Td - 5°C of the oligo-PCR product
hybrid (58°C; calculated in 6x SSC). Both OPs were washed
at 58°C because their Tds - 5°C differed only by 0.3°C.
Immunological detection of PCR product-OP hybrids was
performed by using an anti-digoxigenin alkaline phosphatase
antibody conjugate and enzyme catalyzed colorimetric reac-
tion with 5-bromo-4-chloro-3-indolyl phosphate and nitro-
blue tetrazolium salt as substrates.
RESULTS
RT-PCR amplification of Norwalk virus. The stool samples
used in the initial studies (8FIIa, G-52, G-53, L-152, and
L-153) were obtained from human volunteer studies and
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FIG. 1. RT-PCR and oligoprobing of Norwalk virus. Nucleic
acid of Norwalk virus purified from a stool specimen (sample L-152)
by Sephadex G-200 chromatography was amplified from two differ-
ent genomic regions, an IP region and the Pol region, in separate
reactions (A). Southern transfers were hybridized with OPs to either
the IP region (B) or the Pol region (C). M, DNA markers (DNA
marker V; Boehringer Mannheim Biochemicals); IP+, Norwalk
virus amplified by primers from an immunogenic protein region with
a resulting DNA fragment of 224 bp; IP-, reaction cocktail contain-
ing IP primers but no Norwalk virus; Pol+, Norwalk virus amplified
by primers from the Pol region with a resultingDNA fragment of 260
bp; Pol-, reaction cocktail containing Pol primers but no Norwalk
virus.
solid-phase immunoassay (RIA or EIA) or both methods. As
shown in Fig. 1A, Norwalk virus sequences from the IP and
Pol regions were effectively amplified by the primer pairs
NV-IP and NV-Pol and resulted in the expected amplicons
of 224 and 260 bp, respectively. No amplicons were detected
in Norwalk-negative reaction mixtures (Fig. 1A, lanes
marked with a minus sign). The digoxigenin-labeled probes
NV-Io.IP and NV-Io.Pol, which were internal to their re-
spective amplicons, were used to verify the authenticities of
Norwalk virus-derived PCR DNA fragments. The IP region
OP was specific to the amplified 224-bp DNA fragment (Fig.
1B), and the Pol region OP was specific to the 260-bp
fragment (Fig. 1C).
Sensitivity of RT-PCR. The sensitivity of the RT-PCR
method was determined on a Norwalk virus-containing stool
filtrate, the titer of which was previously determined by IEM
and RIA. RT-PCR detection with the NV-IP and NV-Pol
primer pairs was applied to serial 10-fold dilutions of a
Norwalk virus-positive stool sample (sample L-152) esti-
mated to contain about 106 virions per ml by IEM (6a) and to
have an RIA dilution endpoint titer of about 1:2,048 (103 ).
As shown in Fig. 2, a RT-PCR endpoint titer of 106/ml was
obtained by using each primer set. The safety-tested 8FIIa
stool specimen inoculum used in human volunteer studies
had a similar endpoint titer by RT-PCR (data not shown).
This specimen was previously shown to contain approxi-
mately 106 particles per ml by IEM (17), to have an RIA
dilution endpoint titer of about 103 5/ml (11), and to have a
human infectivity titer of at least 104 infectious doses per ml
(14). These results indicate that RT-PCR is at least 100-fold
more sensitive than RIA and considerably more sensitive
than IEM for Norwalk virus detection in stools. By IEM, it
generally is not possible to detect virions at titers of less than
about 106/ml (the practical detection limit), but by RT-PCR,
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FIG. 2. Sensitivity of RT-PCR for Norwalk virus. Ten-microliter
volumes of serial 10-fold dilutions of a Norwalk virus-positive stool
sample (sample L-152) were assayed by RT-PCR by using each
primer set (POL, polymerase region; IP, immunogenic protein
region) in separate reactions. Both RT-PCR reactions gave a distinct
endpoint of positivity at a i0' dilution, corresponding to 106/ml. M,
DNA markers (marker V; Boehringer Mannheim Biochemicals);
lanes -1 through -7, 10-p±l samples of serial 10-fold dilutions of
Norwalk virus stool specimen containing an estimated 106 virions
per ml.
it was possible to dilute such specimens 10,000-fold and still
detect genomic nucleic acid in a 10-,ul volume.
The endpoints of Norwalk virus RT-PCR titrations were
sharp after 40 cycles of amplification, which is consistent
with RT-PCR endpoint titration results reported previously
for other enteric viruses (4). Norwalk virus RT-PCR titra-
tions had the same endpoints by UV light visualization of
ethidium bromide-stained gels and by digoxigenin-labeled
OP hybridization under the conditions tested in this study.
Specificity of RT-PCR-OP detection. It was considered
essential that the detection method for Norwalk virus not
react with other enteric viruses commonly shed in feces.
Computer-aided analysis of genomic RNA sequences
strongly suggested that the primers selected for Norwalk
virus were specific. Nonetheless, extensive empirical testing
was performed to verify specificity, because sequence infor-
mation on some enteric viruses possibly related to Norwalk
virus is not available. The specificities of both sets of primers
and OPs were determined by performing RT-PCR-OPs on
other calicivirus-like and Norwalk virus-like small, round
gastrointestinal viruses, astroviruses, enteroviruses, and
rotaviruses. By using both Norwalk virus primer-OP sets,
RT-PCR-OP results were negative when tested with human
caliciviruses (specimens UK4, 20682, 1120, R, J, and S), two
feline caliciviruses, a canine calicivirus, Snow Mountain
agent, and hepatitis E virus. Reactions were also negative
for human astrovirus types 1, 2, and 4; Parramatta agent;
Hawaii agent; Taunton agent; 15 enteroviruses (poliovirus
types 1 and 3; coxsackievirus types Al, A5, A9, A12, A17,
B3, and B5; echovirus types 1, 2, 4, 5, 7, and 12); hepatitis A
virus; and group A rotavirus strain Wa and isolate 62 (type
1), isolate 126 (type 2), strain P (type 3), and isolate 204 (type
4). Twenty-six stool specimens from asymptomatic children
and adults were negative by RT-PCR-OP. All of the entero-
viruses and rotaviruses tested were positive by RT-PCR by
using pan-enterovirus or pan-rotavirus primers (data not
shown).
Detection of Norwalk virus in fecal specimens. We next
used our RT-PCR-OP assay to study serial shedding of
Norwalk virus by human volunteers. Detection of Norwalk
virus in stool samples by RT-PCR-OP was compared with
antigen detection by RIA and viral RNA detection by dot
it
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FIG. 3. Detection by RT-PCR-OP of Norwalk virus in serial
stool specimens from experimentally infected human volunteers.
Stool samples were purified by Sephadex G-200 gel chromatogra-
phy, amplified by RT-PCR, transferred by the method of Southern,
and hybridized with Pol and IP oligoprobes simultaneously. Roman
numerals, volunteer number; arabic numerals, stool sample number
(sample no. 1 is the preinfection stool sample). For each stool
sample, the left lane is the Pol oligoprobe (upper bands) and the right
lane is the IP oligoprobe (lower bands). M, DNA molecular weight
markers; NV, Norwalk virus positive control.
blot hybridization with pre- and postinfection stool samples
from five experimentally infected human volunteers. All of
the 20 postinfection stool samples tested by RT-PCR-OP
were previously found to be Norwalk antigen positive by
RIA (positive/negative, >2) (17). All five preinfection stool
samples (I-1, II-1, III-1, IV-1, and V-1) were negative by
RT-PCR-OP when both primer-OP sets were used. By
RT-PCR-OP, 95% (19 of 20) of RIA-positive postinfection
stool samples were positive when the IP primer-OP set
(NV-IP and NV-Io.IP) was used and 70% were positive
when the Pol primer-OP set (NV-Pol and NV-Io.Pol) was
used (Fig. 3). All samples that were positive with the NV-Pol
primers were also positive with the NV-IP primers. Only one
RIA-positive sample (sample IV-7) was RT-PCR-OP nega-
tive with both primer sets. Because of the small amount of
sample available, we were not able to determine whether
RT-PCR was inhibited or viral RNA was degraded.
For stool samples from four of five infected volunteers
(volunteers I, II, III, and V), there was complete agreement
between the results of RT-PCR-OP when both primer-OP
sets were used and there was antigen positivity by RIA.
However, differences in sample positivity were obtained for
postinfection stool samples from volunteer IV. Although all
11 postinfection stool samples were antigen positive by RIA,
10 were positive by RT-PCR-OP when the IP primer-OP set
was used and only 6 were positive when the Pol primer-OP
set was used.
The applicability of the RT-PCR-OP method to the detec-
tion of Norwalk virus in clinical isolates was determined by
using a series of coded stool samples. Twenty-one coded
stool specimens, including several Norwalk virus ETA-pos-
itive stool specimens as well as stool specimens containing
caliciviruses, astroviruses, and an adenovirus, were tested
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FIG. 4. Detection of Norwalk virus by RT-PCR-OP in stool specimens. For agarose gels, 21 coded stool specimens were purified by
Sephadex G-200 spin-column chromatography, amplified by RT-PCR by using Norwalk virus NV-5'Pol and NV-3'Pol primers (left lane below
each number) and NV-5'IP and NV-3'IP primers (right lane below each number) in separate reactions. For hybridization filters, Southern
transfers of amplified reaction products were probed with digoxigenin-labeled oligomers (Pol, left lane; IP, right lane). Lanes: 1, Norwalk
virus, volunteer sample I; 2, Parramatta agent; 3, Norwalk virus, volunteer sample II; 4, negative stool, child; 5, calicivirus J; 6, calicivirus
1120; 7, Norwalk virus, volunteer sample III; 8, astrovirus type 1; 9, negative stool sample, adult; 10, Norwalk virus, volunteer stool sample
collected on the day of infection; 11, Parramatta agent; 12, astrovirus type 4; 13, Norwalk virus volunteer, preinfection stool sample; 14,
calicivirus S; 15, calicivirus R; 16, adenovirus; 17, Norwalk virus, volunteer sample IV preserved in sodium azide; 18, Norwalk virus,
volunteer sample V; 19, Hawaii agent; 20, Taunton agent; 21, Norwalk virus volunteer, early postinfection stool sample (negative by EIA);
22, negative stool sample, child; 23, Norwalk virus positive control stool sample; 24, reagent control; NC, negative controls; M, DNA
molecular weight markers (marker V; Boehringer Mannheim Biochemicals).
for Norwalk virus by RT-PCR-OP. Four samples were
clearly Norwalk virus positive when both primer-OP sets
were used (Fig. 4). These four samples were also EIA
positive. An additional sample that was positive by EIA
(sample 17) but negative by RT-PCR-OP was obtained in
1978 and had been preserved in sodium azide. All samples
negative for Norwalk virus by EIA were also negative by
RT-PCR-OP. Non-Norwalk virus-specific DNA bands were
observed as RT-PCR products in ethidium bromide-stained,
electrophoresed agarose gels of samples containing calicivi-
ruses (Fig. 4). In most cases, these bands were clearly
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Norwalk virus genomic regions amplified, and none of them
reacted with the internal OPs. Thus, the DNA bands of
predicted size in Norwalk virus-positive specimens hybrid-
ized to their respective internal OPs, while all other viruses
present in the samples tested were negative by the complete
RT-PCR-OP test.
DISCUSSION
In order to develop a useful, PCR-based diagnostic test for
Norwalk virus, several important factors must be consid-
ered. The primers and OPs selected for Norwalk virus must
effectively amplify the virus, detect a low copy number of
genomic RNA, and not cross-react with other Norwalk
virus-like or enteric viruses that may be present in stool
specimens. Because a cell culture assay for Norwalk virus
has not been developed, the reagents needed to perform
antibody-based assays are not readily available, and the
genomic relationship to other Norwalk virus-like agents is
not yet known, it was critical to conduct the initial testing of
the primers and OPs on well-characterized stool specimens
containing Norwalk virions. In the study described here, we
demonstrated that RT-PCR-OP is a specific and sensitive
method for the detection of Norwalk virus in stool samples.
RT-PCR-OP is a highly sensitive technique with detection
limits at or below the dose levels that cause clinical illness or
infection. The titration endpoints that we obtained by RT-
PCR-OP of Norwalk virus from stool specimens were more
than 100-fold greater than the dilution endpoint titer detected
by RIA and were equivalent to the estimated virus particle
count obtained by IEM. In samples that contained virions at
the practical limit of IEM detectability of about 106 virions
per ml, RT-PCR detection was achieved in 10-,ul volumes
when such specimens were diluted as much as 10,000-fold.
Stool samples having Norwalk virus RIA or EIA positive/
negative values of 2 or greater were positive by RT-PCR-OP,
with a few noted exceptions. In the two samples which were
positive by RIA and negative by RT-PCR-OP, it is not
known whether the sample clean-up procedure was inade-
quate in removing inhibitors, the genomic RNA had been
degraded, or RIA positivity was due primarily to viral
antigens and not intact virions. One of these samples had a
positive/negative ratio of 5.6 by RIA; nonetheless, it was
negative by cDNA hybridization (17) and RT-PCR. The two
following samples from the same volunteer had positive/
negative ratios of 3.2 and 3.9 by RIA, were positive by
cDNA hybridization (17), and were positive by RT-PCR.
Detection of Norwalk virus by the RT-PCR-OP method
developed in the study described here was specific. Both
sets of primer pairs gave the specific PCR product from
Norwalk virus-positive stools but not from negative control
stools or from a variety of enteric viruses tested. DNA bands
of different sizes were occasionally observed after amplifi-
cation of other caliciviruses. This reactivity may reflect
either some degree of sequence conservation in the RNA Pol
of Norwalk virus and these other viruses or nonspecific
bands not associated with the Pol region of these viruses.
However, no reactivity with the internal OPs was observed
for any viruses tested by hybridization after RT-PCR ampli-
fication. Because the internal OPs hybridized only to their
Norwalk virus-derived amplicons and not to other DNA
bands, oligoprobing of PCR-amplified stool specimens is a
reliable confirmatory step for identification of those stool
samples containing Norwalk virus. Such confirmation seems
to be necessary until other Norwalk virus-like viruses are
sequenced and more specific primers can be selected.
Norwalk virus detectability by RT-PCR with NV-Pol and
NV-IP primers was similar for positive stools from four of
five volunteers and for coded clinical samples. However,
visual observation of PCR products in electrophoresed aga-
rose gels suggested that the NV-IP primers produced more
PCR product than the NV-Pol primers did. The NV-Pol
primers were annealed at a higher temperature (ca. 10°C
above the Tm) than the NV-IP primers were (ca. 5°C above
the Tm). This difference in stringency may have accounted
for the greater yield of PCR product and better detection in
a set of stool samples from one of the five volunteers
(volunteer IV) when the NV-IP primers were used. It is also
possible that inadequate sample preparation affected the
NV-Pol primers more than it did the NV-IP primers. The
NV-IP primers resulted in more non-Norwalk virus-specific
DNA bands than the NV-Pol primers did, with the latter
producing nonspecific bands only with stool samples con-
taining caliciviruses. With the exception of some stool
samples from volunteer IV and one other volunteer sample,
all known Norwalk virus-positive samples tested in the
present study were detected by both primer-OP sets. In a
previous study (17), only 8 of the 20 postinfection stool
samples were positive for Norwalk virus RNA by dot blot
hybridization. On the basis of these results, the RT-PCR-OP
method appears to provide a greater degree of detectability
than does direct hybridization of Norwalk virus RNA in
stool samples.
The processing of virus-containing stool samples by Seph-
adex G-200 spin-column chromatography is a rapid, practi-
cal, and effective approach for removal of factors that
interfere with RT-PCR. Viruses are recovered efficiently in a
buffer compatible with RT-PCR, and they are substantially
free of small proteins, salts, and other nonspecific factors
that might interfere with RT-PCR. The Sephadex G-200 spin
columns can be easily prepared in quantity, stored at 4°C
until use, and centrifuged at room temperature. Because the
recovered virus particles are still intact, the genomic RNA is
protected from enzymatic degradation, and additionally, the
processed stool specimens can be used for electron micros-
copy or immunoassays. After Sephadex G-200 spin-column
chromatography, the sample is heated to 99°C in the thermal
cycler, whereupon the viral RNA is conveniently released
and made available for reverse transcription immediately
before the addition of RT and RNase inhibitors (12). Other
enteric viruses, such as hepatitis A virus, enteroviruses, and
rotaviruses, can also be processed effectively in this manner
(4).
Although other methods are available for the preparation
of stool samples for RT-PCR, they have drawbacks in
comparison with the gel chromatography method used in the
present study. Methods based on phenol-chloroform extrac-
tion, ethanol precipitation of viral RNA, and CF-11 cellulose
chromatography are cumbersome, labor-intensive, time-
consuming, and potentially damaging to the integrity of the
viral genome. Antibody capture of viral antigen on a solid
phase has also been demonstrated to be effective in remov-
ing factors that interfere with RT-PCR from stool samples in
the detection of hepatitis A virus (12). At present, however,
this approach is not applicable to the detection of Norwalk
virus, because the high-quality Norwalk virus-specific anti-
bodies needed for antigen capture are not readily available.
The RT-PCR-OP technique described here is well-suited
for the detection of pedigree Norwalk virus and, as sequence
information becomes available, other Norwalk virus-like
agents of acute gastrointestinal illness. The high degree of
sensitivity of target nucleic acid amplification techniques,
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such as RT-PCR, is important for the detection of nonculti-
vatable viruses because they may be shed in low numbers in
feces and because stool specimens may not be collected
during the period of peak virus shedding. The use of nonra-
dioactive OPs provides a confirmatory test to the clinical
laboratory without the risk of handling radioactive material.
As issues such as false-positive results by PCR product
carryover, false-negative results by factors that interfere
with RT-PCR, primer and OP specificity, and automation
continue to be addressed, PCR technology for the detection
of low levels of fastidious viruses is likely to become ever
more accessible to the clinical diagnostic laboratory (19).
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